Patent Assignment Agreements ▼

<TEXT>

                           PATENT ASSIGNMENT AGREEMENT

THIS PATENT ASSIGNMENT  AGREEMENT  ("Agreement") is entered as of the 1st day of
May 2006  ("EFFECTIVE  DATE") by and  between  WORLD  WASTE  TECHNOLOGIES,  with
offices at 13520  Evening  Creek Drive  North,  Suite 130,  San Diego,  CA 92128
("WWT"),  and The  University  of Alabama in  Huntsville.,  with  offices at 301
Sparkman Drive NW, Huntsville, AL 35805 ("UAH").

WHEREAS,  UAH owns United  . . .

PATENT ASSIGNMENT AGREEMENT

BY AND BETWEEN

LENOVO (BEIJING) LIMITED,

AND

LEGEND HOLDINGS LIMITED

YU BING

WANG ZHENG

for and on behalf of LWY

Agreement Reference Number                    

This PATENT ASSIGNMENT AGREEMENT, dated as of October 19, 2004, is entered into by and between Lenovo (Beijing) Limited, a company established under the laws of the People�s Republic of China ( . . .

PATENT ASSIGNMENT AGREEMENT

This Agreement (the Agreement), is made and entered into this 17^th day of April, 2003, (the Effective Date) by and between NeoRx Corporation, a corporation of Washington, having its principal address at 300 Elliott Avenue West, Suite 500, Seattle, WA 98119 (Grantor), and SciMed Life Systems Inc., a corporation of Minnesota (Grantee), having its principal place of business at One Boston Scientific Place, Natick, Massachusetts 01760, which is a wholly-owned subsidiary of Boston Scientific Corporation, which is guaranteeing certain performance under this Agreement.

RECITALS

A.                                    Grantor has developed technologies relating to [*] and has obtained and acquired patents therefore.

B.                                    Grantee desires to acquire the Assigned Patents (as defined below) upon the terms and conditions set forth in this Agreement.

C.                                    Grantor entered into a license agreement dated as of [*] (the [*] License), a true and correct copy of which is attached hereto as Appendix A and made a part hereof, by and between Grantor and [*] pursuant to which certain license rights under the Assigned Patents were granted to [*].

Agreement

In consideration of the promises and the mutual covenants contained in this Agreement the parties agree as follows:

ARTICLE 1                                DEFINITIONS

For the purposes of this Agreement, the following words and phrases shall have the following meanings:

1.1                               Affiliate of an entity means any other entity that, directly or indirectly, controls, is controlled by, or is under common control with, the entity.  For purposes of this definition, controlledmeans the power, directly or indirectly, to direct or cause the direction of management and policies of such entity whether by contract or otherwise, but an entity shall only be an affiliate of another for so long as such control exists.

1.2                               Assigned Patents means those issued patents and pending patent applications listed in Appendix B, all domestic and foreign patents that issue in the future on those pending patent applications, all future patent applications that claim priority to any of the issued patents or pending patent applications listed in Appendix B ([*]), all domestic and foreign patents that issue in the future on such patent applications and that issue from divisions, continuations, continuations-in-part, reissues, reexaminations, substitutes, and extensions of the foregoing.

3

1.3                               Confidential Information shall have the meaning set forth in article 6.

ARTICLE 2                                ASSIGNMENT OF PATENTS

2.1                               Patent Assignment.  Subject to the terms and conditions of this Agreement and the [*] License, Grantor hereby sells, assigns and transfers to Grantee, and Grantee hereby purchases, acquires and accepts from Grantor, all of Grantors right, title, and interest in and to the Assigned Patents, and all rights and privileges related thereto including without limitation:  (i) all rights to sue others for past, present, and future acts of infringement of the Assigned Patents (ii) to the extent not precluded by law or contract, all obligations to Grantor or its Affiliates, if any, of the inventors of the Assigned Patents relating to the Assigned Patents, including obligations, if any, to assist in prosecution, enforcement, or licensing of the Assigned Patents; and (iii) to retain all revenues received from others for any such past, present and future acts of infringement as described in clause (i) of the Assigned Patents.  Within ten (10) business days after the Effective Date, Grantor shall provide to Grantee the following documents relating to each of the Assigned Patents:  (i) Grantors prosecution history file (including all correspondence with the patent office, but not including between Grantor and outside prosecution counsel or other privileged materials), i.e., file wrapper; (ii) all material prior art (whether patents, patent applications, publications, or events raising a statutory bar to patentability) in the possession of Grantor in documentary form; (iii) all original executed assignment(s) from inventor(s); and (iv) the original ribbon copy of the each issued Assigned Patent.  Within ten (10) business days after a request by Grantee following the Effective Date, Grantor shall:  (i) provide to Grantee, or to Grantees designated outside counsel, the complete files of Grantors outside prosecution counsel relating to any or all Assigned Patents (but not including any privileged materials); and (ii) make available to Grantees representative(s) at Grantors facility in Seattle, Washington, during Grantors normal business hours the originals of all inventors notebook(s) of the inventions included in the Assigned Patents, for inspection and copying.  If needed by Grantee and reasonably requested by Grantee, Grantor will, within ten (10) business days of the request, provide Grantee with copies of any invention disclosure forms pertaining to the particular Assigned Patents if providing such records is not considered to constitute a waiver of Grantors attorney client privilege, taking into consideration whether the parties share a common legal interest with respect to the issue with respect to which Grantee has requested such information; provided, however, that Grantee shall not waive or do any act that would constitute waiver of any privilege associated with such records without the written consent of Grantor and shall not use the records (and any information contained therein) in any manner adverse to Grantor.

2.2                               Cooperation.  Grantor agrees, without further consideration to Grantor but at Grantees sole cost and expense (including, without limitation, reasonable out-of-pocket costs incurred by Grantor at Grantees request), but without charge by Grantor, to cooperate, and to use commercially reasonable efforts to cause their officers, employees, agents, contractors, and others under their direction or control, to cooperate with Grantee in (a) filing or prosecuting any patent applications included in  the Assigned Patents or maintaining any patents included in the Assigned Patents, (b) executing any further legal documents, including any further assignments, such as individual assignments for recordation in any U.S. or foreign offices or agencies, to evidence the assignment of the Assigned Patents, and (c) performing all reasonable acts that may